In vitroactivity of β‐lactams in combination with avibactam against multidrug‐resistantPseudomonas aeruginosa, Stenotrophomonas maltophiliaandAchromobacter xylosoxidansisolates from patients with cystic fibrosis. Issue 9 (September 2018)

• Record Type: Journal Article
• Authors: Mathy, Vincent; Grohs, Patrick; Compain, Fabrice
• Is Part Of: Journal of medical microbiology. Volume 67:Issue 9(2018)
• Publication Date: 2018-09
• Subjects: Achromobacter -- avibactam -- β‐lactam -- cystic fibrosis -- Pseudomonas -- Stenotrophomonas; Medical microbiology -- Periodicals; 616.9041
• DOI: 10.1099/jmm.0.000801
• Languages: English
• ISSNs: 0022-2615

Abstract

Abstract : N/A: The in vitro activity of anti‐pseudomonal β‐lactams in combination with avibactam was evaluated against 54 multidrug‐resistant non‐fermenting Gram‐negative bacilli isolated from cystic fibrosis patients. Avibactam increased and/or restored the antibacterial activities of ceftazidime and aztreonam against Pseudomonas aeruginosa and Stenotrophomonas maltophilia, respectively. No β‐lactam‐avibactam combination was active against Achromobacter xylosoxidans .